Lightbridge Corporation Q1 2026 Earnings Continued Investment in Nuclear Fuel Technology Amidst No Revenue GoodRx Q1 2026 Earnings EPS Misses Estimates Yet Stock Gains 352 AKAM Q1 2026 Earnings EPS Misses Estimates Stock Declines Dogwood Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Preclinical Development INDV Q1 2026 Earnings Strong EPS Beat Underscores Operational Discipline MAC Q1 2026 Earnings BottomLine Miss Weighs on Investor Sentiment